Renal Cancer - Results from #5440

Cabozantinib in the treatment of advanced renal cell carcinoma: clinical trial evidence and experience December 6, 2016

Obesity and Kidney Cancer December 5, 2016

Excess weight as a risk factor common to many cancer sites: words of caution when interpreting meta-analytic evidence December 5, 2016

Safety, Tolerability and Pharmacokinetics of Oral Administration of GW786034 in Patients with Solid Tumors December 4, 2016

Patient perspectives on the barriers associated with medication adherence to oral chemotherapy December 2, 2016

Prediction of Competing Mortality for Decision Making between Surgery or Observation in Elderly Patients with T1 Kidney Cancer November 29, 2016

Advances in Cancer Immunotherapy in Solid Tumors November 28, 2016

The clinical course of venous thromboembolism may differ according to cancer site November 28, 2016

Nivolumab dose selection: challenges, opportunities, and lessons learned for cancer immunotherapy November 28, 2016

Sclerosing TFEB Rearrangement Renal Cell Carcinoma: A Recurring Histologic Pattern November 26, 2016

Therapy of Treatment-Related Hypertension in Metastatic Renal-Cell Cancer Patients Receiving Sunitinib November 25, 2016

[CCAFU french national guidelines 2016-2018 on renal cancer] November 24, 2016

Systematic expression analysis of the mitochondrial complex III subunits identifies UQCRC1 as biomarker in clear cell renal cell carcinoma November 24, 2016

Tuberous sclerosis complex protein 1 expression is affected by VHL Gene alterations and HIF-1α production in sporadic clear-cell renal cell carcinoma. November 24, 2016

Prognostic significance of platelet-lymphocyte ratio in patients receiving first-line tyrosine kinase inhibitors for metastatic renal cell cancer November 24, 2016

The database of the Danish Renal Cancer Group November 24, 2016

Resistance to Targeted Therapies in Renal Cancer: The Importance of Changing the Mechanism of Action November 23, 2016

The European Society for Medical Oncology Magnitude of Clinical Benefit Scale in daily practice: a single institution, real-life experience at the Medical University of Vienna November 23, 2016

Predictive and prognostic biomarkers of targeted agents and modern immunotherapy in renal cell carcinoma November 22, 2016

Sunitinib for the treatment of benign and malignant neoplasms from von Hippel-Lindau disease: A single-arm, prospective phase II clinical study from the PREDIR group November 21, 2016

Page 273 of 456